Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-09
1993-06-01
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142338, 514409, 544145, 548409, 548410, 591 50, A61K 3138, C07D49504
Patent
active
052160203
ABSTRACT:
Substituted 4,5-dihydrothieno[2,3-b]thiophene-2-sulfonamides and 6,6-dioxides thereof are topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma associated therewith.
REFERENCES:
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4585787 (1986-04-01), Shepard
patent: 4668697 (1987-05-01), Shepard et al.
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1987-06-01), Baldwin et al.
patent: 4876271 (1989-10-01), Hartman et al.
patent: 4894390 (1990-01-01), Hartman et al.
patent: 4929549 (1990-05-01), Hartman et al.
patent: 5045561 (1991-09-01), Baldwin et al.
Baldwin John J.
Hudcosky Ronald J.
Shepard Kenneth L.
Williams Theresa M.
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
Robinson Allen J.
Russell Mark W.
LandOfFree
Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814887